Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 5,356 shares at $20.95 ($120K) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $120k ATRA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.95 | 100 | $2K | 1.7% |
| 2 | $22.44 | 5,256 | $118K | 98.3% |
| Total | $22.41 avg | 5,356 | $120K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |